跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,041 条关于
“NTB-928”
全部
3,041
临床试验
2,143
药物
677
机构
24
资讯
197
2个月前
92Bio Doses First Patient in Phase 1 Trial of NTB-928, a Next-Generation Bispecific T-Cell Engager for Platinum-Resistant Ovarian Cancer
去年
Deferiprone Fails to Slow Cognitive Decline in Alzheimer's Disease, Worsens Outcomes
2年前
CEL-SCI Receives FDA Approval for Confirmatory Study of Multikine in Head and Neck Cancer Treatment
去年
CEL-SCI's Cancer Drug Shows 73% Survival Rate, FDA Agrees on PD-L1 Biomarker Use
10个月前
Chiesi Discontinues COPD Drug Tanimilast After Phase III Trial Failure
5个月前
Innovent Advances First-in-Class IBI363 to Pivotal Trials for Immunotherapy-Resistant Lung Cancer
8个月前
CEL-SCI Advances Multikine Toward Registration with 212-Patient Confirmatory Study for Head and Neck Cancer
2年前
Eli Lilly's Once-Weekly Insulin Efsitora Demonstrates Non-Inferior Efficacy in Phase 3 Trials for Type 2 Diabetes
3个月前
Alcohol-Associated Liver Disease Market Poised for 31.1% CAGR Growth as First Disease-Modifying Therapies Near Approval
3年前
Ropeginterferon Alfa-2b Shows Promise in Hydroxyurea-Resistant Essential Thrombocythemia
第 1 页,共 20 页
上一页
下一页